Health
National Vaccination Day: All you need to know about Covid-19 vaccines in India
Vaccination is a crucial part of public health and has been instrumental in eradicating many diseases that were once considered deadly. The World Health Organization (WHO) estimates that vaccination saves approximately 2–3 million lives worldwide each year. On National Vaccination Day, we bring to you all the Covid-19 vaccines available in India.
Here is the list of COVID-19 vaccines available in India:
Sputnik V
Sputnik V is the first registered vaccine against Covid-19. This vaccine was developed by Russia`s Gamaleya Research Institute of Epidemiology and Microbiology. Sputnik V is administered in two doses, with a gap of three weeks between the doses. The age criteria for the Sputnik V vaccine is 18 years of age and above. This vaccine has been authorized for emergency use in several countries, including India.
Covishield
The Covishield vaccine is manufactured by the Serum Institute of India (SII), a company based in Pune that has been approved by the WHO. Covishield is administered in two doses, with a gap of four to six weeks between the doses. The age criteria for the Covishield vaccine is 18 years of age and above. This vaccine has been authorized for emergency use around the globe, including India.
COVAXIN
Covaxin is an indigenous vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). Covaxin is administered in two doses, with a gap of four weeks between the doses. People under the age of 18 can get themselves vaccinated with Covaxin. The Indian regulatory authority has granted Covaxin emergency use authorization, and it is now being used in the country`s vaccination campaign.
Zydus Cadila Vaccine (ZyCoV-D)
The ZyCoV-D vaccine is developed by the Indian pharmaceutical company Cadila Healthcare Limited. ZyCoV-D is administered in three doses, with a gap of four weeks between the doses. The age criteria for the ZyCoV-D vaccine is 12 years of age and older. It has received emergency use authorization from the Indian regulatory authority.
Covovax
Covovax, also known as Novavax, is a vaccine developed by Novavax Inc., an American biotechnology company. Covovax is administered in two doses, with a gap of three weeks between the doses. The age criteria for the Covovax (Novavax) vaccine is 12 years of age and above.
BBV154 – intranasal Vaccine (iNCOVACC)
Bharat Biotech has developed a nasal vaccine for COVID-19. This vaccine works as a nasal spray. The iNVOCACC vaccine is administered through the nose in two separate doses. The Government of India has approved this vaccine, which is available at government and private hospitals. The iNCOVACC vaccine is only available to people over the age of 18.
In conclusion, India has a wide range of Covid-19 vaccines available for public use, ranging from indigenous vaccines to those developed by foreign companies. These vaccines have shown varying efficacy rates, but all of them have undergone rigorous testing and have received emergency use authorization from the Indian regulatory authority.
Visakhapatnam: Health 360°, the healthcare division of Australia-based humanitarian group of companies Global 360°, has signed an investment agreement with public entity Andhra Pradesh Medtech Zone Limited (AMTZ). The strategic partnership will help build and develop healthcare facilities in Vizag which will be equipped with world-class facilities and life-saving medical equipment, to be provided by AMTZ.
The first in a series of healthcare projects in the pipeline is a 200-bed greenfield hospital built in two stages with each stage having 100 beds. It is scheduled for completion in mid-2023. The hospital will provide a wide and diverse range of medical specialties and procedures. Health 360° CEO, Dr Guru Yajaman, said: “We are honoured to have AMTZ onboard for this collaboration as we see a valued partner in them. They are one of the leading medical technology manufacturers in the world. This is a massive initiative that is very close to our hearts and consistent with our mission to deliver seamless healthcare experience to the people of India.”
Dr Jitendra Sharma, MD and CEO of AMTZ, said: “We are thrilled to announce that AMTZ is committed to working with Health 360° to revolutionise the healthcare industry. This partnership marks the beginning of a new era in the democratisation of medical technology. This would be the first hospital in India to be operated using only ‘Made in India’ medical equipment.”
Health
C3 Introduces Innovative Menstrual Hygiene Kit to Empower Young School Girls, Health News, ET HealthWorld
Pataudi, Haryana: To help young girls navigate puberty – which is often a time of significant physical and emotional upheaval – C3 has been working in five schools of Pataudi district, Haryana. The initiative is supported by Open Text, and has been equipping over 1000 adolescent girls with life skills, digital and financial literacy, and information on menstrual health and hygiene.
C3 introduced an unique, first-of-its-kind resource – ‘Navya Kits’ – to the girls under this intervention. A collection of products and information that would help these young girls understand and manage their periods and dispel myths and taboos surrounding menstruation, these Navya Kits are a cornerstone for adolescent menstrual hygiene. The kits contain six reusable pads (that would last up to 2 years), a hot water bottle for menstrual pain management, a diary with interactive information on menstrual hygiene and taboos, and a detergent bottle that will help the girls wash and re-use their pads. To further supplement wider usage and safe disposal of sanitary napkins, C3 has also begun setting up incinerators in all of the five schools in which the initiative has been running.The Navya kits are also an essential tool for future advocacy around menstrual hygiene, and is something C3 will aim to disseminate through its other adolescent health initiatives as well.
At the launch event, Vandana Nair, Lead, Adolescent and Young People Program at C3, further emphasized the importance of educating young girls about menstrual hygiene, stating that “Menstruation is a natural bodily process that they will likely experience for several decades. By providing them with accurate information and resources, we can help them understand and manage their menstrual cycle and dispel any myths or taboos surrounding menstruation.”
Dr Tanaya Narendra, popularly known as Dr Cuterus, an Instagram influencer with over a million followers and author, was also present at the launch, and interacted directly with the young girls to answer their pressing concerns, to encourage them to have open conversations around menstruation, and providing valuable insights on how young girls can maintain their menstrual health. According to Dr. Cuterus, “this initiative by Centre for Catalyzing Change (C3) is absolutely unique, fun, and important for all the adolescent girls between the ages of 11-13. The products in the Navya kit will help young girls be prepared for their first period and also give them the right information in an engaging manner.”
Ms. Pushpanjali Saikia, CSR Lead India from Micro Focus now Open Text, reasserted the need to provide girls with all the necessary information to help them achieve both better health and future success. This includes digital literacy, larger emotional and physical wellbeing, and the confidence to seek out better opportunities and better life choices in today’s increasingly digitized world.
Health
Government hikes duty on X-ray machine imports to 15 pc from Apr 1, Health News, ET HealthWorld
The government has hiked customs duty on import of X-ray machines and non-portable X-ray generators to 15 per cent with effect from April 1. Currently, portable X-ray machines and non-portable X-ray generators and apparatus attract 10 per cent import duty.
The changes in the customs duty rate was brought in as part of the amendments to the Finance Bill, 2023, which was passed by the Lok Sabha last Friday.
The new rates would be effective from April 1, 2023, the amendment said.
AMRG & Associates Senior Partner Rajat Mohan said this is intended to improve barriers to manufacturing in India. “This will encourage ‘Make in India’ to reduce import dependence in the niche sector,” he said.
Gordon Moore, Intel Co-Founder and Coiner of Moore’s Law, Dies at 94
Official status & exit permit, but above all, dignity
Morning brief: TMC MP slams BJP leaders for sharing stage with Bilkis rapist | Latest News India
EC’s proposal on allowing e-postal ballot for overseas Indian voters under discussion: Law Minister tells Rajya Sabha
Sensex closes 127 points lower, RIL down 2.3 pc
Elon Musk claims to donate ₹826 crore to OpenAI before it became profitable
-
News1 week ago
EC’s proposal on allowing e-postal ballot for overseas Indian voters under discussion: Law Minister tells Rajya Sabha
-
Business1 week ago
Sensex closes 127 points lower, RIL down 2.3 pc
-
Tech1 week ago
Elon Musk claims to donate ₹826 crore to OpenAI before it became profitable
-
News1 week agoTwitch CEO Emmett Shear to Step Down after More Than 16 Years
-
Entertainment1 week agoFilmmaker Anand Kumar says his film on Sukesh Chandrasekhar is not a biopic; says he want to show the conman as the mastermind that he is | Hindi Movie News
-
India1 week agoMorning brief: Pakistan minister on nuclear programme amid economic crisis | Latest News India
-
Health1 week agoDream interpreters reveal why we dream and what do they really mean
-
Business1 week agoTcs: TCS CEO Rajesh Gopinathan quits; K Krithivasan to replace him